| Fonds | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 21.583.233 $ | +1.246.356 $ | +6,1 % | 232.590.033 $ | +40.471.390 $ | +22,9 % | 193.111.566 $ | -24.624.255 $ | -11,1 % | 217.735.821 $ | +1.663.289 $ | +2,0 % | |
| Matrix Capital Management Company, LP | 46.314.000 $ | +8.584.358 $ | +22,8 % | 37.729.642 $ | -5.053.695 $ | -11,8 % | 42.783.337 $ | -553.829 $ | -1,3 % | |||
| Frazier Life Sciences Management, L.P. | 34.119.000 $ | +6.324.000 $ | +22,8 % | 27.795.000 $ | -3.723.000 $ | -11,8 % | 31.518.000 $ | -408.000 $ | -1,3 % | |||
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 32.654.726 $ | +6.052.595 $ | +22,8 % | 26.602.131 $ | -3.563.222 $ | -11,8 % | 30.165.353 $ | -390.490 $ | -1,3 % | |||
| Long Focus Capital Management, LLC | 30.905.004 $ | +5.728.282 $ | +22,8 % | 25.176.722 $ | -3.372.295 $ | -11,8 % | 28.549.017 $ | -369.566 $ | -1,3 % | |||
| SUVRETTA CAPITAL MANAGEMENT, LLC | 29.254.594 $ | +5.422.376 $ | +22,8 % | 23.832.218 $ | -3.192.205 $ | -11,8 % | 27.024.423 $ | -349.831 $ | -1,3 % | |||
| BlackRock, Inc. | 23.994.623 $ | +4.590.313 $ | +23,7 % | 19.404.310 $ | -1.641.539 $ | -7,8 % | 21.045.849 $ | +1.624.049 $ | +8,4 % | |||
| Medicxi Ventures Management (Jersey) Ltd | 21.583.233 $ | +1.246.356 $ | +6,1 % | 20.336.877 $ | +3.769.466 $ | +22,8 % | 16.567.411 $ | -2.219.122 $ | -11,8 % | 18.786.533 $ | -243.191 $ | -1,3 % |
| VANGUARD GROUP INC | 16.004.132 $ | -1.859.177 $ | -10,4 % | 17.863.309 $ | +2.354.147 $ | +15,2 % | ||||||
| VANGUARD CAPITAL MANAGEMENT LLC | 15.011.209 $ | |||||||||||
| 21.583.233 $ | +1.246.356 $ | +6,1 % | 232.590.033 $ | +40.471.390 $ | +22,9 % | 193.111.566 $ | -24.624.255 $ | -11,1 % | 217.735.821 $ | +1.663.289 $ | +2,0 % | |